Tuesday, April 16, 2024

NEWS

NEWS

Uzbekistan and China will produce anti-SARS-COV-2 coronavirus vaccine

Tashkent, Aug 12 (Prensa Latina) Chinese biopharmaceutical company Anhui Zhifei Longcom and Uzbek Jurabek Laboratories announced today the signing of an agreement for the purchase and production in this country of Chinese vaccines against Covid-19.

August 12, 2021
09:54

The Uzbek company has prepared a separate line for the production of the Anhui Zhifei Longkom Biopharmaceutical vaccine, which has already been audited by Chinese experts, TASS news agency reported.

It is expected that in the near future a series will be developed for the validation of the vaccine, after which its production will be authorized.

The drug to be developed in Uzbekistan will be obtained by producing the recombining protein NCP-RBD from SARS-CoV-2 coronavirus.

pgh/lcp

#Uzbekistan China vaccine production

17:17

Cuba thanks Namibian parliament for motion against US blockade

17:12

UN pledges some 600 million dollars to boost aid to Ethiopia

17:07

Bolivian trade unionists maintain protest in downtown La Paz

17:06

CELAC proposes commission to check Jorge Glas´ health conditions

17:02

Cuba supports Mexico after attack on Embassy in Ecuador

16:57

Argentinian workers condemn layoffs at National Library

Cuba thanks Namibian parliament for motion against US blockade

April 16, 2024
5:17 pm

UN pledges some 600 million dollars to boost aid to Ethiopia

April 16, 2024
5:12 pm

Bolivian trade unionists maintain protest in downtown La Paz

April 16, 2024
5:07 pm

CELAC proposes commission to check Jorge Glas´ health conditions

April 16, 2024
5:06 pm

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado, Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division Prensa Latina.